scholarly journals Competitive Treatment in Diffuse Large B-cell lymphoma (DLBCL) and the Future SOC for the First Line Therapy

2018 ◽  
Vol 06 (01) ◽  
Author(s):  
Timothey Allen ◽  
Ghazaleh Shoja E Razavi ◽  
Nepton Sheikh Khoni ◽  
Naveed Basha
Keyword(s):  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
First Line ◽  
First Line Therapy ◽  
Large B Cell Lymphoma ◽  
Line Therapy ◽  
The Future ◽  
Competitive Treatment ◽  
Large B Cell

scholarly journals Prognostic significance of infectious episodes occurring during first‐line therapy for diffuse large B‐cell lymphoma ‐ A nationwide cohort study

2020 ◽  
Vol 38 (3) ◽  
pp. 318-325
Author(s):  
Michael R. Clausen ◽  
Sinna P. Ulrichsen ◽  
Maja B. Juul ◽  
Christian B. Poulsen ◽  
Brian Iversen ◽  
...  
Keyword(s):  
Cohort Study ◽  
B Cell ◽  
Cell Lymphoma ◽  
Prognostic Significance ◽  
B Cell Lymphoma ◽  
First Line ◽  
First Line Therapy ◽  
Large B Cell Lymphoma ◽  
Line Therapy ◽  
Large B Cell

Pegfilgrastim as hematopoietic support for dose-dense chemoimmunotherapy with R-CHOP-14 as first-line therapy in elderly patients with diffuse large B cell lymphoma

2007 ◽  
Vol 15 (7) ◽  
pp. 877-884 ◽  
Author(s):  
Ulrich J. M. Mey ◽  
Anna Maier ◽  
Ingo G. H. Schmidt-Wolf ◽  
Carsten Ziske ◽  
Helmut Forstbauer ◽  
...  
Keyword(s):  
Elderly Patients ◽  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
First Line ◽  
First Line Therapy ◽  
Large B Cell Lymphoma ◽  
Line Therapy ◽  
Dose Dense ◽  
Large B Cell
Sign in / Sign up

Export Citation Format

Share Document